Elie Arslan

Elie Arslan has a long and varied career in Quality Assurance and Regulatory Affairs. Starting in 2004 as a Microbiologist at Gish Biomedical, they then moved to Gilead Sciences as a Quality Control Specialist II in 2008. In 2011, they took on the role of Quality Assurance Specialist I at Sangart, followed by a Senior Quality Assurance Associate role at Tanvex Biopharma USA, Inc. in 2013. In 2014, they became Quality Manager at Sherpa Clinical Packaging, where they managed the company's quality systems, procedures and policies, internal and vendor audits, and hosted over 120 client, FDB and QP audits. In 2018, they moved to Codex DNA as Senior Manager, Quality Systems, where they managed cGMP disposition of patient specific and neoantigen shared gene therapy clinical products and shipments, and improved KPIs for Quality Systems. In 2020, they began at Ajinomoto Bio-Pharma Services as Manager, Technical QA and Document Control, managing a team of Document Control and Technical Quality Groups. Finally, in 2022 they took on the role of Associate Director of Quality Assurance, Facilities and Program Management, and Associate Director of Quality Assurance at Cellics Therapeutics, Inc.

Elie Arslan obtained a B.S. in Microbiology from California State Polytechnic University-Pomona between 2001 and 2004. Elie then went on to obtain an MBA in Global Management from the University of Phoenix between 2005 and 2007. In 2009, they earned a M.S. in Biotechnology from The Johns Hopkins University, with a concentration in Regulatory Affairs. Additionally, Elie Arslan has obtained multiple certifications, including Program Management Foundations and What Is Program Management? from LinkedIn in October 2022, Antimicrobial resistance - theory and methods from DTU - Technical University of Denmark in September 2021, Good Clinical Practice from The National Institute on Drug Abuse (NIDA) in November 2019, and Six Sigma Green Belt (CSSGB) from Board of Regents of the University System of Georgia.